mesalamine has been researched along with Labor, Premature in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rahimi, R | 1 |
| Nikfar, S | 1 |
| Rezaie, A | 1 |
| Abdollahi, M | 1 |
| Sachar, D | 1 |
1 review available for mesalamine and Labor, Premature
| Article | Year |
|---|---|
Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; | 2008 |
1 other study available for mesalamine and Labor, Premature
| Article | Year |
|---|---|
Exposure to mesalamine during pregnancy increased preterm deliveries (but not birth defects) and decreased birth weight.
Topics: Abnormalities, Drug-Induced; Adult; Anti-Inflammatory Agents, Non-Steroidal; Birth Weight; Case-Cont | 1998 |